195 related articles for article (PubMed ID: 37176539)
1. Prognostic Models Using Machine Learning Algorithms and Treatment Outcomes of Occult Breast Cancer Patients.
Qu J; Li C; Liu M; Wang Y; Feng Z; Li J; Wang W; Wu F; Zhang S; Zhao X
J Clin Med; 2023 Apr; 12(9):. PubMed ID: 37176539
[TBL] [Abstract][Full Text] [Related]
2. Novel models by machine learning to predict prognosis of breast cancer brain metastases.
Li C; Liu M; Zhang Y; Wang Y; Li J; Sun S; Liu X; Wu H; Feng C; Yao P; Jia Y; Zhang Y; Wei X; Wu F; Du C; Zhao X; Zhang S; Qu J
J Transl Med; 2023 Jun; 21(1):404. PubMed ID: 37344847
[TBL] [Abstract][Full Text] [Related]
3. Survival analysis and nomogram for early-stage occult breast cancer with positive lymph nodes based on the SEER database.
Man X; Xu H; Wang H; Zhao J; Chen X; Yin S; Tan Q; Huang J; Sun S; Zhou D; Zheng F; Liu T; Song L; Zhang B; Li N; Li H
Ann Transl Med; 2022 Dec; 10(24):1351. PubMed ID: 36660717
[TBL] [Abstract][Full Text] [Related]
4. Different Clinicopathological Characteristics and Prognostic Factors for Occult and Non-occult Breast Cancer: Analysis of the SEER Database.
Huang KY; Zhang J; Fu WF; Lin YX; Song CG
Front Oncol; 2020; 10():1420. PubMed ID: 32974151
[No Abstract] [Full Text] [Related]
5. Reconceptualizing the clinicopathological features, locoregional therapy and prognostic factors of occult breast cancer in the era of molecular subtyping.
Ye X; Yang L; He Q; Lin X; Wang J; Cui R; Xu C
Women Health; 2023 Feb; 63(2):105-114. PubMed ID: 36576239
[TBL] [Abstract][Full Text] [Related]
6. Machine learning predicts the prognosis of breast cancer patients with initial bone metastases.
Li C; Liu M; Li J; Wang W; Feng C; Cai Y; Wu F; Zhao X; Du C; Zhang Y; Wang Y; Zhang S; Qu J
Front Public Health; 2022; 10():1003976. PubMed ID: 36225783
[TBL] [Abstract][Full Text] [Related]
7. A novel web-based prognostic nomogram and the features influencing the curative effect of chemotherapy and radiotherapy for Paget's disease with invasive ductal carcinoma.
Qu J; Li C; Liu M; Wang Y; Sun S; Feng Z; Wu F; Zhang S; Zhao X
Am J Cancer Res; 2023; 13(10):4508-4530. PubMed ID: 37970339
[TBL] [Abstract][Full Text] [Related]
8. The association between molecular type and prognosis of patients with stage IV breast cancer: an observational study based on SEER database.
Hou L; Qiu M; Chen M; Li F; Li J; Deng S; Yang Y; Du Z; Yang H
Gland Surg; 2021 Jun; 10(6):1889-1898. PubMed ID: 34268073
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of post-mastectomy adjuvant chemotherapy for the treatment of patients with prognostic stage IB breast cancer: A SEER-based study.
Wang H; Peng Y; Wu J; Chen Z; Zhang H
Asian J Surg; 2023 Sep; 46(9):3634-3641. PubMed ID: 37210259
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics and overall survival prognostic nomogram for metaplastic breast cancer.
Zheng C; Fu C; Wen Y; Liu J; Lin S; Han H; Han Z; Xu C
Front Oncol; 2023; 13():1030124. PubMed ID: 36937402
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Factors and a Model for Occult Breast Cancer: A Population-Based Cohort Study.
Zhang D; Zhai J; Li L; Wu Y; Ma F; Xu B
J Clin Med; 2022 Nov; 11(22):. PubMed ID: 36431280
[TBL] [Abstract][Full Text] [Related]
12. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
Front Immunol; 2022; 13():947802. PubMed ID: 36405735
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological characteristics and treatment outcomes of occult breast cancer: a population-based study.
Zhao Z; Zhang T; Yao Y; Lu X
BMC Surg; 2022 Apr; 22(1):143. PubMed ID: 35430796
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors and survival according to tumour subtype in women presenting with breast cancer bone metastases at initial diagnosis: a SEER-based study.
Li X; Zhang X; Liu J; Shen Y
BMC Cancer; 2020 Nov; 20(1):1102. PubMed ID: 33187507
[TBL] [Abstract][Full Text] [Related]
15. Adequate lymph node dissection is essential for accurate nodal staging in intrahepatic cholangiocarcinoma: A population-based study.
Zhu J; Liu C; Li H; Ren H; Cai Y; Lan T; Wu H
Cancer Med; 2023 Apr; 12(7):8184-8198. PubMed ID: 36645113
[TBL] [Abstract][Full Text] [Related]
16. Epidemiological trends and novel prognostic evaluation approaches of patients with stage II-IV colorectal neuroendocrine neoplasms: A population-based study with external validation.
Zhao F; Huang L; Wang Z; Wei F; Xiao T; Liu Q
Front Endocrinol (Lausanne); 2023; 14():1061187. PubMed ID: 36817582
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a Surveillance, Epidemiology, and End Results (SEER)-based prognostic nomogram for predicting survival in gastric cancer with multi-organ metastases.
Wang T; Liu C; Wang W; Huang B; Yu R; Huang M; Dong W
Transl Cancer Res; 2022 Jun; 11(6):1534-1551. PubMed ID: 35836507
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Score for
Ji L; Fan L; Zhu X; Gao Y; Wang Z
Front Oncol; 2021; 11():651636. PubMed ID: 34513662
[TBL] [Abstract][Full Text] [Related]
19. Predicting diagnosis and survival of bone metastasis in breast cancer using machine learning.
Zhong X; Lin Y; Zhang W; Bi Q
Sci Rep; 2023 Oct; 13(1):18301. PubMed ID: 37880320
[TBL] [Abstract][Full Text] [Related]
20. Nomograms for Predicting the Risk and Prognosis of Liver Metastases in Pancreatic Cancer: A Population-Based Analysis.
Shi H; Li X; Chen Z; Jiang W; Dong S; He R; Zhou W
J Pers Med; 2023 Feb; 13(3):. PubMed ID: 36983591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
